Suppr超能文献

法尼酯X受体缺乏在喂食高脂饮食的低密度脂蛋白受体敲除小鼠中诱发非酒精性脂肪性肝炎。

Farnesoid X receptor deficiency induces nonalcoholic steatohepatitis in low-density lipoprotein receptor-knockout mice fed a high-fat diet.

作者信息

Kong Bo, Luyendyk James P, Tawfik Ossama, Guo Grace L

机构信息

Department of Pharmacology, Toxicology, and Therapeutics, University of Kansas Medical Center. 3901 Rainbow Blvd., Kansas City, KS 66160, USA.

出版信息

J Pharmacol Exp Ther. 2009 Jan;328(1):116-22. doi: 10.1124/jpet.108.144600. Epub 2008 Oct 23.

Abstract

Nonalcoholic steatohepatitis (NASH) comprises dysregulation of lipid metabolism and inflammation. Identification of the various genetic and environmental susceptibility factors for NASH may provide novel treatments to limit inflammation and fibrosis in patients. This study utilized a mouse model of hypercholesterolemia, low-density lipoprotein receptor knockout (LDLr(-/-)) mice fed a high-fat diet for 5 months, to test the hypothesis that farnesoid X receptor (FXR) deficiency contributed to NASH development. Either the high-fat diet or FXR deficiency increased serum alanine aminotransferase activity, whereas only FXR deficiency increased bile acid and alkaline phosphatase levels. FXR deficiency and high-fat feeding increased serum cholesterol and triglycerides. Although high fat led to macrosteatosis and hepatocyte ballooning in livers of mice regardless of genotype, no inflammatory infiltrate was observed in the livers of LDLr(-/-) mice. In contrast, in the livers of LDLr(-/-)/FXR(-/-) mice, foci of inflammatory cells were observed occasionally when fed the control diet and were greatly increased when fed the high-fat diet. Consistent with enhanced inflammatory cells, hepatic levels of tumor necrosis factor alpha and intercellular adhesion molecule-1 mRNA were increased by the high-fat diet in LDLr(-/-)/FXR(-/-) mice. In agreement with elevated levels of procollagen 1 alpha 1 and TGF-beta mRNA, type 1 collagen protein levels were increased in livers of LDLr(-/-)/FXR(-/-) mice fed a high-fat diet. In conclusion, FXR deficiency induces pathologic manifestations required for NASH diagnosis in a mouse model of hypercholesterolemia, including macrosteatosis, hepatocyte ballooning, and inflammation, which suggest a combination of FXR deficiency and high-fat diet is a risk factor for NASH development, and activation of FXR may be a therapeutic intervention in the treatment of NASH.

摘要

非酒精性脂肪性肝炎(NASH)包括脂质代谢失调和炎症。识别NASH的各种遗传和环境易感性因素可能会为限制患者炎症和纤维化提供新的治疗方法。本研究利用高胆固醇血症小鼠模型,即低密度脂蛋白受体敲除(LDLr(-/-))小鼠,喂食高脂饮食5个月,以检验法尼醇X受体(FXR)缺乏导致NASH发展的假设。高脂饮食或FXR缺乏均会增加血清丙氨酸氨基转移酶活性,而只有FXR缺乏会增加胆汁酸和碱性磷酸酶水平。FXR缺乏和高脂喂养会增加血清胆固醇和甘油三酯。尽管高脂饮食会导致无论基因型如何的小鼠肝脏出现大泡性脂肪变性和肝细胞气球样变,但在LDLr(-/-)小鼠肝脏中未观察到炎症浸润。相反,在LDLr(-/-)/FXR(-/-)小鼠肝脏中,喂食对照饮食时偶尔会观察到炎症细胞灶,喂食高脂饮食时则会显著增加。与炎症细胞增多一致,高脂饮食使LDLr(-/-)/FXR(-/-)小鼠肝脏中肿瘤坏死因子α和细胞间黏附分子-1 mRNA水平升高。与I型前胶原α1和转化生长因子-β mRNA水平升高一致,喂食高脂饮食的LDLr(-/-)/FXR(-/-)小鼠肝脏中I型胶原蛋白水平升高。总之,在高胆固醇血症小鼠模型中,FXR缺乏会诱发NASH诊断所需的病理表现,包括大泡性脂肪变性、肝细胞气球样变和炎症,这表明FXR缺乏与高脂饮食相结合是NASH发展的危险因素,激活FXR可能是治疗NASH的一种治疗干预措施。

相似文献

1
Farnesoid X receptor deficiency induces nonalcoholic steatohepatitis in low-density lipoprotein receptor-knockout mice fed a high-fat diet.
J Pharmacol Exp Ther. 2009 Jan;328(1):116-22. doi: 10.1124/jpet.108.144600. Epub 2008 Oct 23.
2
FXR deficiency causes reduced atherosclerosis in Ldlr-/- mice.
Arterioscler Thromb Vasc Biol. 2006 Oct;26(10):2316-21. doi: 10.1161/01.ATV.0000235697.35431.05. Epub 2006 Jul 6.
8
Loss of FXR protects against diet-induced obesity and accelerates liver carcinogenesis in ob/ob mice.
Mol Endocrinol. 2012 Feb;26(2):272-80. doi: 10.1210/me.2011-1157. Epub 2012 Jan 19.
9
Dietary cholesterol exacerbates hepatic steatosis and inflammation in obese LDL receptor-deficient mice.
J Lipid Res. 2011 Sep;52(9):1626-35. doi: 10.1194/jlr.M016246. Epub 2011 Jun 20.
10
Experimental Nonalcoholic Steatohepatitis and Liver Fibrosis Are Ameliorated by Pharmacologic Activation of Nrf2 (NF-E2 p45-Related Factor 2).
Cell Mol Gastroenterol Hepatol. 2017 Dec 13;5(3):367-398. doi: 10.1016/j.jcmgh.2017.11.016. eCollection 2018 Mar.

引用本文的文献

1
Antifibrotic therapies for metabolic dysfunction-associated steatotic liver disease.
JHEP Rep. 2025 Apr 11;7(8):101421. doi: 10.1016/j.jhepr.2025.101421. eCollection 2025 Aug.
2
Inflammation in MASLD progression and cancer.
JHEP Rep. 2025 Apr 2;7(8):101414. doi: 10.1016/j.jhepr.2025.101414. eCollection 2025 Aug.
3
Deletion of hepatic FXR leads to more severe MASH development in female mice.
Hepatol Commun. 2025 May 16;9(6). doi: 10.1097/HC9.0000000000000693. eCollection 2025 Jun 1.
5
Effects of intestine-specific deletion of fibroblast growth factor 15 on alcoholic liver disease development in mice.
Liver Res. 2022 May 10;6(2):84-92. doi: 10.1016/j.livres.2022.05.001. eCollection 2022 Jun.
6
Farnesoid X receptor and fibroblast growth factor 15/19 as pharmacological targets.
Liver Res. 2021 Mar 9;5(3):142-150. doi: 10.1016/j.livres.2021.02.002. eCollection 2021 Sep.
7
Transcription factors, metabolic dysfunction-associated fatty liver disease, and therapeutic implications.
Genes Dis. 2024 Jul 5;12(3):101372. doi: 10.1016/j.gendis.2024.101372. eCollection 2025 May.
10
Pipeline of New Drug Treatment for Non-alcoholic Fatty Liver Disease/Metabolic Dysfunction-associated Steatotic Liver Disease.
J Clin Transl Hepatol. 2024 Sep 28;12(9):802-814. doi: 10.14218/JCTH.2024.00123. Epub 2024 Jul 31.

本文引用的文献

1
Prevention of hepatic fibrosis in a murine model of metabolic syndrome with nonalcoholic steatohepatitis.
Am J Pathol. 2008 Oct;173(4):993-1001. doi: 10.2353/ajpath.2008.070720. Epub 2008 Sep 4.
4
Expression and function of the bile acid receptor TGR5 in Kupffer cells.
Biochem Biophys Res Commun. 2008 Jul 18;372(1):78-84. doi: 10.1016/j.bbrc.2008.04.171. Epub 2008 May 9.
5
Bile acid levels are increased in the liver of patients with steatohepatitis.
Eur J Gastroenterol Hepatol. 2008 Jun;20(6):519-25. doi: 10.1097/MEG.0b013e3282f4710a.
7
Non-alcoholic fatty liver disease and the metabolic syndrome: an update.
World J Gastroenterol. 2008 Jan 14;14(2):185-92. doi: 10.3748/wjg.14.185.
8
The pathogenesis of ethanol versus methionine and choline deficient diet-induced liver injury.
Biochem Pharmacol. 2008 Feb 15;75(4):981-95. doi: 10.1016/j.bcp.2007.09.030. Epub 2007 Oct 18.
9
Independent predictors of steatohepatitis and fibrosis in Asian Indian patients with non-alcoholic steatohepatitis.
Dig Dis Sci. 2008 Jul;53(7):1967-76. doi: 10.1007/s10620-007-0074-0. Epub 2007 Nov 21.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验